Scandinavian Journal of Pain
Volume 1, Issue 3 , Pages 143-148 , July 2010

The effects of gabapentin in human experimental pain models

  • Thomas P. Enggaard

      Affiliations

    • Department of Anaesthesiology and Intensive Care Medicine, Odense University Hospital, Denmark
    • Clinical Pharmacology, University of Southern Denmark, Denmark
    • Corresponding Author InformationCorresponding author at: Department of Anaesthesiology and Intensive Care Medicine, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark.
    • ,
  • Søren S. Mikkelsen

      Affiliations

    • Department of Anaesthesiology and Intensive Care Medicine, Odense University Hospital, Denmark
    • ,
  • Stine T. Zwisler

      Affiliations

    • Department of Anaesthesiology and Intensive Care Medicine, Odense University Hospital, Denmark
    • Clinical Pharmacology, University of Southern Denmark, Denmark
    • ,
  • Niels A. Klitgaard

      Affiliations

    • Section of Clinical Pharmacology, Clinical Biochemistry and Clinical Genetics, Odense University Hospital, Denmark
    • ,
  • Søren H. Sindrup

      Affiliations

    • Clinical Pharmacology, University of Southern Denmark, Denmark
    • Department of Neurology, Odense University Hospital, Denmark

Received 18 December 2009 ,Revised 18 April 2010 ,Accepted 19 April 2010.

References 

  1. Staahl C, Olesen AE, Andresen T, Arendt-Nielsen L, Drewes AM. Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review. Br J Clin Pharmacol. 2009;68:322–341
  2. Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment for neuropathic pain. Basic Clin Pharmacol Toxicol. 2005;96:399–409
  3. Enggaard TP, Poulsen L, Arendt-Nielsen L, Hansen SH, Björnsddottir I, Gram LF, et al. The analgesic effect of codeine as compared to imipramine in different human experimental pain models. Pain. 2001;92:277–282
  4. Enggaard TP, Klitgaard NA, Gram LF, Arendt-Nielsen L, Sindrup SH. Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans. Clin Pharmacol Ther. 2001;69:245–251
  5. Arendt-Nielsen L, Brennum J, Sindrup S, Bak P. Electrophysiological and psychophysical quantification of temporal summation in the human nociceptive system. Eur J Appl Physiol Occup Physiol. 1994;68:266–273
  6. Eide PK. Wind-up and the NMDA receptor complex from a clinical perspective. Eur J Pain. 2000;4:5–15
  7. Gottrup H, Andersen J, Arendt-Nielsen L, Jensen TS. Psychophysical examination in patients with post-mastectomy pain. Pain. 2000;87:275–284
  8. Svendsen KB, Jensen TS, Hansen HJ, Bach FW. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain. 2005;114:473–481
  9. Jones SF, McQuay HJ, Moore RA, Hand CW. Morphine and ibuprofen compared using the cold pressor test. Pain. 1988;34:117–122
  10. Webb J, Kamali F. Analgesic effects of lamotrigine and phenytoin on cold-induced pain: a cross-over placebo-controlled study in healthy volunteers. Pain. 1998;76:357–363
  11. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118:289–305
  12. Dirks J, Petersen KL, Rowbotham MC, Dahl JB. Gabapentin suppresses cutaneous hyperanalgesia following heat-capsaicin sensitization. Anesthesiology. 2002;97:102–107
  13. Eckhardt K, Ammon S, Hofmann U, Riebe A, Gugeler N, Mikus G. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg. 2000;91:185–191
  14. Werner MU, Perkins FM, Holte K, Pedersen JL, Kehlet H. Effects of gabapentin in acute inflammatory pain in humans. Reg Anesth Pain Med. 2001;26:322–328
  15. Stewart BH, Kugler AR, Thompson PR, Bockbrader HN. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharm Res. 1993;10:276–281
  16. Arendt-Nielsen L, Frøkjaer JB, Staahl C, Graven-Nielsen T, Huggins JP, Smart TS, et al. Effects of gabapentin on experimental somatic pain and temporal summation. Reg Anesth Pain Med. 2007;32:382–388
  17. Enggaard TP, Klitgaard NA, Sindrup SH. Specific effect of levetiracetam in experimental human pain models. Eur J Pain. 2006;10:193–198
  18. Lindberger M, Luhr O, Johannesen SI, Larsson S, Tomson T. Serum concentrations and effect of gabapentin and vigabatrin: observations from a dose titration study. Ther Drug Monit. 2003;25:457–462
  19. Gottrup H, Juhl G, Kristensen AD, Lai R, Chizh BA, Brown J, et al. Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia. Anesthesiology. 2004;101:1400–1408
  20. Arendt-Nielsen L, Petersen-Felix S, Fischer M, Bak P, Bjerring P, Zbinden AM. The effect of N-methyl-d-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study. Anesth Analg. 1995;81:63–68
  21. Max MB, Byas-Smith MG, Gracely RH, Bennett GJ. Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin Neuropharmacol. 1995;18:360–368
  22. Eide PK, Jorum E, Stubhauge A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-d-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 1994;58:347–354
  23. Gottrup H, Bach FW, Juhl G, Jensen TS. Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain. Anaesthesiology. 2006;104:527–536
  24. Vilholm OJ, Cold S, Rasmussen L, Sindrup SH. Effect of levetiracetam on the postmastectomy pain syndrome. Eur J Neurol. 2008;15:851–857
  25. Vilholm OJ, Cold S, Rasmussen L, Sindrup SH. Sensory function and pain in a population of patients treated for breast cancer. Acta Anaesthesiol Scand. 2009;53:800–806

☆ Preliminary results from this study were presented as a poster at the 80th IARS Clinical and Scientific Congress, San Francisco, CA, USA, March 24–26, 2006 and at the 30th Annual Meeting, in Scandinavian Association for the Study of Pain (SASP), Stockholm, Sweden, May 4–7, 2006.

PII: S1877-8860(10)00048-0

doi: 10.1016/j.sjpain.2010.04.001

Scandinavian Journal of Pain
Volume 1, Issue 3 , Pages 143-148 , July 2010

Article Tools

* Image Usage & Resolution